Skip header and navigation

12 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
April 8, 2020 Is the IgM or IgG immune response protective? LAB040803-01 ESR Laboratory
April 11, 2020 Is the IgM or IgG immune response protective? LAB040803 RR Laboratory
April 14, 2020 At what time in the disease timeline of COVID-19 do antibodies develop? LAB041402-01 ESR Laboratory
April 15, 2020 At what time in the disease timeline of COVID-19 do antibodies develop? LAB041402 RR Laboratory
May 8, 2020 What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update] LAB040701v2 RR Laboratory
May 8, 2020 What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update] LAB040701v2-01 ESR Laboratory
May 12, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901-01 ESR Epidemiology & Modelling
May 19, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901 RR Epidemiology & Modelling
May 19, 2020 What is the relationship between antibody development and viral shedding and infectiousness? [Update] LAB041601v2 RR Laboratory
May 22, 2020 What is the relationship between antibody development and viral shedding and infectiousness? [Update] LAB041601v2-01 ESR Laboratory
January 4, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2-01 ESR EOC
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR EOC

12 records – page 1 of 1.